REVERT: Combined Flow and Pressure Study of Craniospinal Dynamic

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Recruiting
CT.gov ID
NCT05068128
Collaborator
University Hospital, Caen (Other), University Hospital, Brest (Other)
60
1
36
1.7

Study Details

Study Description

Brief Summary

Normal pressure hydrocephalus (NPH) can cause a type of dementia. However, this type of dementia is the only one that is reversible. To treat this dementia it is necessary to evacuate the accumulation of CSF from the brain to another body cavity using a device called a shunt. But the implantation of this shunt is only effective when the cause of the pathology is an alteration of the normal circulation of the CSF. To diagnose these patients, morphological MRI and lumbar puncture are standard approaches used but remain perfectible in diagnostic terms.

The main objective is to build a new model of the interaction of intracranial pressures and fluids in order to obtain a new parameter allowing to obtain information on the cerebral biomechanics.

Condition or Disease Intervention/Treatment Phase
  • Other: Flow MRI
  • Other: PERFUSION TEST

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Combined Flow-pressure Study of Cerebrospinal Circulation Using CSF Perfusion Tests and Phase-contrast MRI - Reversible Dementia Substudy
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Variation of number of MRICP parameters according of CSF accumulation [up to 3 years]

    The MRICP parameter will combine the CSF pressure and CSF flows. MRICP parameter results of the interaction of intracranial pressures and fluids in order allowing to obtain information on the cerebral biomechanics. Accumulation of CSF from the brain to another body cavity is neccessary to be determined.

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age > 55 years

  • Patients with suspected active hydrocephalus (HA) known as "normal pressure":

  • Ventricular dilatation: Evans index > 0.3

  • Patients with cognitive impairment, and/or gait disorders and/or urinary incontinence or a combination of these three symptoms.

  • Absence of other neurological diseases that could cause ventriculomegaly.

  • Information and collection of the patient's non opposition

Exclusion Criteria:
  • All patients with neurological disease other than active hydrocephalus will be excluded.

  • Individuals who cannot tolerate an MRI examination

  • All individuals with implants, pacemakers, prostheses and ferromagnetic objects

  • Patients under guardianship, curators or safeguard of justice

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Salouël France 80480

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens
  • University Hospital, Caen
  • University Hospital, Brest

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT05068128
Other Study ID Numbers:
  • PI2021_843_0017
First Posted:
Oct 5, 2021
Last Update Posted:
Oct 15, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire, Amiens
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 15, 2021